Tickr
Home Explore Daily Brief Market Watchlists Portfolio
Research
Catalysts Signal Factory Screener Market News Event Calendar Valuation Plot Heat Map Top Investors Industry Trends Options
AI Assistant Notifications Account
Sera Prognostics, Inc. logo

Sera Prognostics, Inc. (SERA) Stock Ticker

NASDAQ: SERA · Healthcare · Medical - Diagnostics & Research
$2.02-0.98%
USD · as of 2026-09-29 · market cap $77.1M
Open SERA in TickrDownload for iPhone

SERA right now

Options price it to move more than 9 in 10 stocks.
Options expect by Oct 6±22.0%
Options expect by Oct 29±45.5%
Priced in for Nov 12 earnings±55.1%
IV rank (30-day)67% · fair
From Tickr's live models · 2026-09-29. Not investment advice.

Market factors today

Tickr 500 vs S&P 500+0.49%+1.0% MTD
Momentum L/S+1.35%+15.1% MTD
High-beta momo L/S+1.46%+22.2% MTD
Rate sensitivity L/S+1.91%+6.9% MTD
Oil sensitivity L/S-2.54%-5.3% MTD
Unprofitable tech-1.43%+3.7% MTD

Unlock the full SERA picture

🔒 Implied move chart & probabilities
🔒 Live options flow
🔒 AI analysis & chat on SERA
🔒 Catalysts & earnings
🔒 Strategy Lab
🔒 Financials & estimates
Start your 7-day free trial

About Sera Prognostics, Inc.

Sera Prognostics, Inc. is a women's health diagnostics firm that focuses on creating, advancing, and bringing to market biomarker tests aimed at improving pregnancy results. Their primary product, the PreTRM test, is a blood-based biomarker assay specifically designed to predict the likelihood of spontaneous preterm birth in singleton pregnancies where no symptoms are yet present. Additionally, the company is cultivating a portfolio of potential tests for various other pregnancy-related conditions, such as preeclampsia, predicting time-to-birth at a molecular level, gestational diabetes mellitus, restricted fetal growth, stillbirth, and postpartum depression. Established in 2008, the organization's main operations are based in Salt Lake City, Utah.

SERA stock facts

Ticker symbolSERA
ExchangeNASDAQ Global Market
SectorHealthcare
IndustryMedical - Diagnostics & Research
Market cap$77.1M
CEOZhenya Lindgardt
Employees72
HeadquartersSalt Lake City, UT, US
IPO date2021-07-15
Websitewww.sera.com

What you can see for SERA on Tickr

Live SERA price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the SERA report.

Rankings

Largest Healthcare companiesLargest companies by market cap

FAQ

What is the ticker symbol for Sera Prognostics, Inc.?

The ticker symbol for Sera Prognostics, Inc. is SERA, listed on the NASDAQ Global Market.

What is SERA?

Sera Prognostics, Inc. is a women's health diagnostics firm that focuses on creating, advancing, and bringing to market biomarker tests aimed at improving pregnancy results. Their primary product, the PreTRM test, is a blood-based biomarker assay specifically designed to predict the likelihood of spontaneous preterm birth in singleton pregnancies where no symptoms are yet present. Additionally,…

HomeExploreMarketLists
All pages